Cellectis SA ADR buy Quitte
Start price
29.02.16
/
50%
€21.07
Target price
18.03.16
€24.35
Performance (%)
15.63%
End price
18.03.16
€24.36
Summary
This prediction ended on 18.03.16 with a price of €24.36. The prediction had a final performance of 15.63%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cellectis SA ADR | -0.752% | -0.752% | 135.714% | 50.857% |
| iShares Core DAX® | 1.750% | 2.660% | 6.825% | 50.936% |
| iShares Nasdaq 100 | 4.301% | 6.593% | 40.472% | 94.136% |
| iShares Nikkei 225® | 9.895% | 18.278% | 67.990% | 77.793% |
| iShares S&P 500 | 2.542% | 3.062% | 26.763% | 67.591% |
Comments by Quitte for this prediction
In the thread Cellectis SA ADR diskutieren
gutes Rating und eventuell ein Boden
Shares of Cellectis SA (NASDAQ:CLLS) have received a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that provide coverage for the stock, Zacks Investment Research reports. Four analysts have rated the stock with a strong buy recommendation.
(Zielkurs erreicht)

